Clinical studies are expensive, time consuming, and are often challenged with patient recruitment and effective participation. OneMedNet enables our data users to improve the outcomes of clinical studies and product development in speed and quality, while minimizing complexity and reducing costs.
This de-identified image-centric data is used in Discovery, Development, Regulatory Approval, and Post-Market Surveillance. OneMedNet iRWD enables the enrollment and participation of the most under-served populations into clinical research which is a significant benefit to all.
Imaging Real World Data holds the promise to bring the benefits of both Imaging as proof of effectiveness, and Real-World Data’s delivery of safer solutions that are less expensive and faster to market.